“…Overall, buparvaquone resistance-associated SNPs were reported for the first time in buffalo-and cattle-derived T. annulata field isolates and their impact on positive selection pressure. Our results are consistent with the study of the pyrimethamine resistance mutations in the protozoan parasite Plasmodium vivax (Auliff et al, 2006;Brega et al, 2004;de Pecoulas et al, 1998;Hastings et al, 2005;Imwong et al, 2003;Kaur et al, 2006;Kuesap et al, 2011;Lu et al, 2012;Mint Lekweiry et al, 2012;Ranjitkar et al, 2011;Schunk et al, 2006;Shaukat et al, 2019) and diminazene resistance in the Trypanosoma brucei (Carter et al, 1999;Mäser et al, 1999;Matovu et al, 2001). A possible explanation for the differences in the frequency of buparvaquone-conferring mutations with positive selection pressure may be variable drug doses, for example, if the 262S (TCA), 253S (TCT) and 129G (GGC)/253S (TCT) resistance mutations may be selected at low doses of buparvaquone, while 129G (GGC) may occur at higher doses.…”